12916_2019_1408_MOESM1_ESM.pdf (1.02 MB)
Additional file 1: of Prospective analysis of circulating metabolites and breast cancer in EPIC
journal contribution
posted on 2019-09-24, 03:37 authored by Mathilde His, Vivian Viallon, Laure Dossus, Audrey Gicquiau, David Achaintre, Augustin Scalbert, Pietro Ferrari, Isabelle Romieu, N. Onland-Moret, Elisabete Weiderpass, Christina Dahm, Kim Overvad, Anja Olsen, Anne Tjønneland, Agnès Fournier, Joseph Rothwell, Gianluca Severi, Tilman Kühn, Renée Fortner, Heiner Boeing, Antonia Trichopoulou, Anna Karakatsani, Georgia Martimianaki, Giovanna Masala, Sabina Sieri, Rosario Tumino, Paolo Vineis, Salvatore Panico, Carla Gils, Therese Nøst, Torkjel Sandanger, Guri Skeie, J. Quirós, Antonio Agudo, Maria-Jose Sánchez, Pilar Amiano, José Huerta, Eva Ardanaz, Julie Schmidt, Ruth Travis, Elio Riboli, Konstantinos Tsilidis, Sofia Christakoudi, Marc Gunter, Sabina RinaldiSupplementary tables describing the completeness of the metabolites measures (Table S1.) and metabolites concentrations by case-control status (Table S2..); Supplementary figures showing age-adjusted correlations between metabolites in control participants (Figure S1.) and adjusted P values for associations between metabolites and different breast cancer subtypes (Figure S2.). Abbreviations: BMI: Body Mass Index; EPIC: European Prospective Investigation into Cancer and nutrition; ER: estrogen receptor; FDR: False Discovery Rate; HER2: Human epidermal growth factor receptor 2; IARC: International Agency for Research on Cancer; MHT: menopause hormone therapy; MS: Mass spectrometry; NMR: nuclear magnetic resonance; OR: odds ratio; PC: phosphatidylcholine; PR: progesterone receptor; SD: standard deviation; WC: waist circumference. (PDF 1041 kb)
